Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

BACKGROUND: We evaluated preoperative CA 19-9 levels in patients with resected pancreatic cancer to analyze whether they were predictive of clinical outcomes and could help select patients for additional therapy. We hypothesized that elevated CA 19-9 would be associated with worse pathologic finding...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalchuk, Roman O., Lester, Scott C., Graham, Rondell P., Harmsen, William S., Zhang, Lizhi, Halfdanarson, Thorvardur R., Smoot, Rory L., Gits, Hunter C., Ma, Wen Wee, Owen, Dawn, Mahipal, Amit, Miller, Robert C., Wittich, Michelle A. Neben, Cleary, Sean P., McWilliams, Robert R., Haddock, Michael G., Hallemeier, Christopher L., Truty, Mark J., Merrell, Kenneth W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147692/
https://www.ncbi.nlm.nih.gov/pubmed/34046346
http://dx.doi.org/10.3389/fonc.2021.651119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147692/
https://www.ncbi.nlm.nih.gov/pubmed/34046346
http://dx.doi.org/10.3389/fonc.2021.651119

Ejemplares similares